Filing
Spy
Filing
Spy
Home
About
KRTX — Karuna Therapeutics Inc - FilingSpy
KRTX
Karuna Therapeutics Inc
Biopharmaceutical company focused on neurological and psychiatric treatments
CUSIP: 48576A100
Healthcare
US
3 holders
Ownership
Activity
Fundamentals
2022 Q2
7 of 14 quarters
Total Value
$172.26M
Total Shares
1.36M
Net Share Change
+127.6K
Activity
2 buying
1 selling
Investor
Value
Shares
Weight
Change
Viking Global Investors
$141.61M
1.12M
0.6%
ADD
+145.0K
(+14.9%)
Viking Global Investors
$141.61M
1.12M shares
ADD
+145.0K
(+14.9%)
Miller Value Partners
$28.21M
223.0K
1.4%
TRIM
-18.9K
(-7.8%)
Miller Value Partners
$28.21M
223.0K shares
TRIM
-18.9K
(-7.8%)
Patient Capital Management
$2.44M
19.3K
1.1%
ADD
+1.5K
(+8.4%)
Patient Capital Management
$2.44M
19.3K shares
ADD
+1.5K
(+8.4%)